Health Care [ 6/12 ] | Pharmaceuticals [ 14/75 ]
NYSE MKT | Common Stock
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older.
It also provides NITRICIL, a proprietary nitric oxide-based technology platform.
The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025.
Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 13, 25 | -5.30 Decreased by -70.97% | -0.57 Decreased by -829.82% |
| Aug 13, 25 | -5.38 Increased by +1.50% | -6.26 Increased by +14.06% |
| May 28, 25 | -3.21 | - |
| Nov 13, 24 | -2.90 | -2.30 Decreased by -26.09% |
| Aug 13, 24 | -3.10 | -2.90 Decreased by -6.90% |
| May 29, 24 | -5.46 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 7.41 M Increased by +N/A% | -16.24 M Decreased by -858.19% | Decreased by -219.25% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -3.45 M Decreased by -94.68% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -1.97 M Increased by +23.21% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -1.93 M Increased by +52.30% | Decreased by N/A% - |
| Sep 30, 24 | 0.00 - | -1.69 M - | Decreased by N/A% - |
| Jun 30, 24 | 0.00 - | -1.77 M - | Decreased by N/A% - |
| Mar 31, 24 | 0.00 - | -2.56 M - | Decreased by N/A% - |
| Dec 31, 23 | N/A - | -4.04 M - | - - |